These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14614070)

  • 1. Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse.
    Lever MS; Nelson M; Ireland PI; Stagg AJ; Beedham RJ; Hall GA; Knight G; Titball RW
    J Med Microbiol; 2003 Dec; 52(Pt 12):1109-1115. PubMed ID: 14614070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice.
    Lever MS; Nelson M; Stagg AJ; Beedham RJ; Simpson AJ
    Int J Exp Pathol; 2009 Feb; 90(1):16-25. PubMed ID: 19200247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the common marmoset to study Burkholderia mallei infection.
    Jelesijevic T; Zimmerman SM; Harvey SB; Mead DG; Shaffer TL; Estes DM; Michel F; Quinn FD; Hogan RJ; Lafontaine ER
    PLoS One; 2015; 10(4):e0124181. PubMed ID: 25860021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 5. Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei).
    Fritz DL; Vogel P; Brown DR; Deshazer D; Waag DM
    Vet Pathol; 2000 Nov; 37(6):626-36. PubMed ID: 11105952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.
    Ulrich RL; Amemiya K; Waag DM; Roy CJ; DeShazer D
    Vaccine; 2005 Mar; 23(16):1986-92. PubMed ID: 15734072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of
    Dyke JS; Huertas-Diaz MC; Michel F; Holladay NE; Hogan RJ; He B; Lafontaine ER
    Virulence; 2020 Dec; 11(1):1024-1040. PubMed ID: 32799724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using real-time PCR to specifically detect Burkholderia mallei.
    Ulrich MP; Norwood DA; Christensen DR; Ulrich RL
    J Med Microbiol; 2006 May; 55(Pt 5):551-559. PubMed ID: 16585642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.
    Zimmerman SM; Long ME; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Vet Pathol; 2018 Mar; 55(2):258-267. PubMed ID: 29145795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.
    Treviño SR; Permenter AR; England MJ; Parthasarathy N; Gibbs PH; Waag DM; Chanh TC
    Infect Immun; 2006 Mar; 74(3):1958-61. PubMed ID: 16495574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
    Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
    Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection.
    Zimmerman SM; Michel F; Hogan RJ; Lafontaine ER
    PLoS One; 2015; 10(5):e0126437. PubMed ID: 25993100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective cellular responses to Burkholderia mallei infection.
    Rowland CA; Lever MS; Griffin KF; Bancroft GJ; Lukaszewski RA
    Microbes Infect; 2010 Oct; 12(11):846-53. PubMed ID: 20542133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.
    Schully KL; Bell MG; Ward JM; Keane-Myers AM
    PLoS One; 2014; 9(12):e115066. PubMed ID: 25503969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence of Burkholderia mallei quorum-sensing mutants.
    Majerczyk C; Kinman L; Han T; Bunt R; Greenberg EP
    Infect Immun; 2013 May; 81(5):1471-8. PubMed ID: 23429539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.
    Hatcher CL; Mott TM; Muruato LA; Sbrana E; Torres AG
    Infect Immun; 2016 Aug; 84(8):2345-54. PubMed ID: 27271739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autotransporter protein BatA is a protective antigen against lethal aerosol infection with
    Lafontaine ER; Chen Z; Huertas-Diaz MC; Dyke JS; Jelesijevic TP; Michel F; Hogan RJ; He B
    Vaccine X; 2019 Apr; 1():100002. PubMed ID: 33826684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.
    Goodyear A; Jones A; Troyer R; Bielefeldt-Ohmann H; Dow S
    J Immunol; 2010 Feb; 184(3):1445-54. PubMed ID: 20042590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.